Ripple Therapeutics Corporation Canada

Research

Date range: 1 March 2021 - 28 February 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Ripple Therapeutics Corporation published between 1 March 2021 - 28 February 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Ripple Therapeutics Corporation
Count Share
1 0.68

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.68
1 0.68
1 0.68

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.00 0.00 0.00 0.00 0.00

Compare Ripple Therapeutics Corporation with other institutions

Collaboration

Date range: 1 March 2021 - 28 February 2022

International vs. domestic collaboration by Share

  • 60.59% Domestic
  • 39.41% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Ripple Therapeutics Corporation by Share (3 total)

  1. Ripple Therapeutics Corporation and McMaster University (0.85)
    Ripple Therapeutics Corporation0.68
    McMaster University0.17
  2. Ripple Therapeutics Corporation and University of Toronto (U of T) (0.72)
    Ripple Therapeutics Corporation0.68
    University of Toronto (U of T)0.04
  3. Ripple Therapeutics Corporation and Ted Rogers Centre for Heart Research (0.69)
    Ripple Therapeutics Corporation0.68
    Ted Rogers Centre for Heart Research0.01

Top 10 international collaborators with Ripple Therapeutics Corporation by Share (2 total)

  1. Ripple Therapeutics Corporation and University of Montana (UMT) (0.74)
    Ripple Therapeutics Corporation0.68
    University of Montana (UMT)0.06
  2. Ripple Therapeutics Corporation and Xyzagen, Inc. (0.74)
    Ripple Therapeutics Corporation0.68
    Xyzagen, Inc.0.06